Streetbeat News

Stock Prices

MATICUSD

Polygon's (CRYPTO: MATIC) price has seen a significant increase of 4.74% over the past 24 hours, reaching $1.13. Over the last week, MATIC's price has risen over 6%, from $1.05. The coin's trading volume has surged by 22% in the past week, while its circulating supply slightly decreased by 0.08%, now at 92.83% of its max supply. Currently, MATIC's market cap ranks #17, valued at $10.32 billion.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 7:01 pm

EBS

Emergent BioSolutions (NYSE:EBS) is scheduled to release its quarterly earnings report on March 5, 2024, with analysts expecting an EPS of $-0.19. The company's past earnings performance shows a pattern of not meeting EPS estimates, leading to significant stock price fluctuations. Shares have declined by 69.54% over the last year, indicating negative sentiment among long-term shareholders. Investors will be closely watching for both the earnings outcome and the company's future guidance.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 7:01 pm

PTVE

Pactiv Evergreen (NASDAQ:PTVE) has been analyzed by 9 analysts, showing a diverse range of perspectives with an average 12-month price target of $15.94, indicating a 26.71% increase from the previous target. The company operates in foodservice and beverage cartons, facing revenue challenges but showing strong profitability and effective cost management. Analysts' ratings and price targets have been adjusted based on recent developments and financial performance.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 7:00 pm

JWN

Nordstrom (NYSE:JWN) is scheduled to release its quarterly earnings report on March 5, 2024, with an estimated EPS of $0.86. Analysts and investors will be closely watching for not only an earnings beat but also positive guidance for the next quarter. Historically, Nordstrom's share price has shown sensitivity to both earnings outcomes and forward-looking statements. Last quarter, Nordstrom exceeded EPS estimates but saw a 4.63% decline in share price the following day. Over the past year, JWN shares have increased by 6.43%, indicating a generally positive outlook from long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 7:00 pm

ETHUSD

Ethereum (ETH) has seen a 3.31% increase in price over the last 24 hours, reaching $3,588.46, continuing a positive trend with a 13.0% gain over the past week from $3,146.18. Its all-time high is $4,878.26. Trading volume for ETH has risen by 27.0% over the past week, while its market cap ranks #2 at $428.88 billion.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 7:00 pm

GOOGL

META

JPMorgan analyst Doug Anmuth provided insights into the AI stock battle between Alphabet Inc (GOOGL/GOOG) and Meta Platforms Inc (META), rating both as Overweight but with Alphabet having a higher upside potential of 19% compared to Meta's 9%. Alphabet's growth is attributed to advancements in generative AI and a diversified portfolio, while Meta's position is bolstered by its scale, AI investments, and the initiation of a dividend.

Portfolio Pulse from Surbhi Jain

March 04, 2024 | 6:58 pm

AHR

American Healthcare REIT Inc (NYSE:AHR) completed its IPO in February, offering 64.4 million shares at $12.00 each. The company, focusing on healthcare real estate, is now covered by Truist Securities, RBC Capital Markets, and JMP Securities with Buy, Outperform, and Market Outperform ratings respectively, and price targets ranging from $15 to $17. Analysts highlight the company's strong earnings growth potential, driven by post-COVID recovery and strategic relationships, despite its trading at a discount and the risks associated with its RIDEA structure and SNF operational exposure.

Portfolio Pulse from Vandana Singh

March 04, 2024 | 6:56 pm

DECK

SMCI

WHR

ZION

Deckers Outdoor Corporation (NYSE:DECK) shares rose after the announcement of its inclusion in the S&P 500, replacing Whirlpool Corp. (NYSE:WHR) and Zions Bancorp (NASDAQ:ZION) along with Super Micro Computer, Inc. (NASDAQ:SMCI). DECK's year-to-date share growth exceeds 37%, with nearly 70% gains in 2023. Analysts have a positive outlook on DECK, with an average 12-month price target of $853.72, suggesting potential for further growth.

Portfolio Pulse from Erica Kollmann

March 04, 2024 | 6:53 pm

CMPS

ENVB

GHRS

IXHL

MNMD

PSIL

Clinical trials show psilocybin-assisted therapy's potential for treating Generalized Anxiety Disorder. Incannex Healthcare (NASDAQ:IXHL) conducted the Phase 2 study. Enveric Biosciences (NASDAQ:ENVB) announced non-binding deals to license drug compounds for mental health treatments. Compass Pathways (NASDAQ:CMPS), GH Research (NASDAQ:GHRS), MindMed (NASDAQ:MNMD), and other companies reported financial results and business updates. AdvisorShares Psychedelics ETF (NYSE:PSIL) and several US-listed companies showed varied stock performance.

Portfolio Pulse from Lara Goldstein

March 04, 2024 | 6:48 pm

CLRB

Cellectar Biosciences Inc (NASDAQ:CLRB) announced positive results from a Phase 1 trial of iopofosine I 131 for head and neck squamous cell carcinoma, showing a 64% complete remission rate and 73% ORR. Despite treatment-related adverse events, the outcomes position CLRB as an attractive acquisition target, according to Roth Capital, which set a price target of $20. Additionally, CLRB's CLOVER WaM study for Waldenstrom’s macroglobulinemia met its primary endpoint with a 61% MRR.

Portfolio Pulse from Vandana Singh

March 04, 2024 | 6:48 pm